• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腙配体衍生的铜(II)配合物的合成、晶体结构、表征及催化性能

Synthesis, Crystal Structures, Characterization and Catalytic Property of Copper(II) Complexes Derived from Hydrazone Ligands.

作者信息

Tan Yao, Lei Yan

出版信息

Acta Chim Slov. 2021 Mar;68(1):44-50.

PMID:34057527
Abstract

A new bromido-coordinated mononuclear copper(II) complex [Cu(HL1)Br2] (1), and a new mononuclear copper(II) complex [CuL2(HL2)]ClO4·0.5H2O (2), with the hydrazone ligands 4-tert-butyl-N'-(1-(pyridin-2-yl)ethylidene)benzohydrazide (HL1) and 4-bromo-N'-(pyridin-2-ylmethylene)benzohydrazide (HL2), have been synthesized and structurally characterized by physico-chemical methods and single crystal X-ray determination. X-ray analysis indicates that the Cu atom in complex 1 is in distorted square pyramidal coordination, and that in complex 2 is in octahedral coordination. The catalytic property for epoxidation of styrene by the complexes was evaluated.

摘要

合成了一种新的溴配位单核铜(II)配合物[Cu(HL1)Br2](1)和一种新的单核铜(II)配合物[CuL2(HL2)]ClO4·0.5H2O(2),其腙配体分别为4-叔丁基-N'-(1-(吡啶-2-基)亚乙基)苯甲酰肼(HL1)和4-溴-N'-(吡啶-2-基亚甲基)苯甲酰肼(HL2),并通过物理化学方法和单晶X射线测定对其进行了结构表征。X射线分析表明,配合物1中的铜原子处于扭曲的四方锥配位,配合物2中的铜原子处于八面体配位。评估了这些配合物对苯乙烯环氧化的催化性能。

相似文献

1
Synthesis, Crystal Structures, Characterization and Catalytic Property of Copper(II) Complexes Derived from Hydrazone Ligands.腙配体衍生的铜(II)配合物的合成、晶体结构、表征及催化性能
Acta Chim Slov. 2021 Mar;68(1):44-50.
2
Synthesis, Crystal Structures, Characterization and Catalytic Property of Manganese(II) Complexes Derived from Hydrazone Ligands.腙类配体衍生的锰(II)配合物的合成、晶体结构、表征及催化性能
Acta Chim Slov. 2020 Dec;67(4):1233-1238.
3
Synthesis, Characterization, Crystal Structures, and Urease Inhibition of Copper(II) and Zinc(II) Complexes Derived from Benzohydrazones.苯甲酰腙铜(II)和锌(II)配合物的合成、表征、晶体结构及脲酶抑制活性
Acta Chim Slov. 2020 Dec;67(4):1155-1162.
4
Synthesis, Crystal Structures and Catalytic Oxidation Property of Two Oxidovanadium(V) Complexes with Schiff bases.两种含席夫碱的氧化钒(V)配合物的合成、晶体结构及催化氧化性能
Acta Chim Slov. 2024 May 22;71(2):288-294. doi: 10.17344/acsi.2024.8720.
5
Synthesis, Crystal Structures and Catalytic Property of Oxidovanadium(V) Complexes with N’-(4-Oxopentan-2-ylidene)nicotinohydrazide and 4-Bromo-N’-(4-oxopentan.含N'-(4-氧代戊-2-亚基)烟酰肼和4-溴-N'-(4-氧代戊基)氧化钒(V)配合物的合成、晶体结构及催化性能
Acta Chim Slov. 2020 Sep;67(3):927-933.
6
Two Oxidovanadium(V) Complexes with Hydrazone Ligands: Synthesis, Crystal Structures and Catalytic Oxidation Property.两个含腙配体的氧化钒(V)配合物的合成、晶体结构和催化氧化性能。
Acta Chim Slov. 2022 Mar 15;69(1):235-242. doi: 10.17344/acsi.2021.7296.
7
Syntheses, Characterization, Crystal Structures and Antimicrobial Activity of 4-Bromo-N'-(pyridin-2-ylmethylene)benzohydrazide and Its Cobalt(III) and Manganese(II) Complexes.4-溴-N'-(吡啶-2-基亚甲基)苯甲酰肼及其钴(III)和锰(II)配合物的合成、表征、晶体结构与抗菌活性
Acta Chim Slov. 2019 Dec;66(4):1002-1009.
8
Synthesis, Crystal Structures and Urease Inhibition of 4-Bromo-N'-(1-(pyridin-2-yl)ethylidene)benzohydrazide and Its Dinuclear Copper(II) Complex.4-溴-N'-(1-(吡啶-2-基)亚乙基)苯甲酰肼的合成、晶体结构及对尿素酶的抑制作用及其双核铜(II)配合物
Acta Chim Slov. 2021 Dec 15;68(4):804-810. doi: 10.17344/acsi.2021.6781.
9
Helical-chain copper(II) complexes and a cyclic tetranuclear copper(II) complex with single syn-anti carboxylate bridges and ferromagnetic exchange interactions.具有单个顺-反式羧酸盐桥和铁磁交换相互作用的螺旋链状铜(II)配合物及环状四核铜(II)配合物
Inorg Chem. 2000 Jun 26;39(13):2882-90. doi: 10.1021/ic991209k.
10
Synthesis, Characterization and Crystal Structures of Cobalt(II), Zinc(II) and Cadmium(II) Complexes Derived from 2-Hydroxy-N'-(pyridin-2-ylmethylene)benzohydrazide with Antimicrobial Activity.由2-羟基-N'-(吡啶-2-基亚甲基)苯甲酰肼衍生的具有抗菌活性的钴(II)、锌(II)和镉(II)配合物的合成、表征及晶体结构
Acta Chim Slov. 2019 Sep;66(3):675-680.